We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MicroRNAs Are Key Genomic Regulators

By Biotechdaily staff writers
Posted on 26 Jan 2005
A recently published paper has revealed that as much as 30% of the human genome may be regulated by microRNAs, RNA fragments of 18 to 25 nucleotides that bind to mRNA molecules and interfere with protein synthesis.

Investigators at the Massachusetts Institute of Technology (Boston, USA) capitalized on the most up-to-date genome-sequencing data to compare the human genome to that of the dog, chicken, mouse, and rat and correlate correspondence between microRNAs and protein-encoding genes in the different species.

They reported in the January 14, 2005, issue of Cell that the nucleotide sequence of regulatory microRNAs has been conserved for at least 310 million years. More...
MicroRNAs were found to have direct regulatory effects on more than 5,300 human genes, which comprise 30% of the genome.

"It is exciting to see how many genes are regulated by microRNAs. We now know that this type of gene control is much more widespread than previously appreciated,” said senior author Dr. David Bartel, professor of biology at the Massachusetts Institute of Technology.




Related Links:
Massachusetts Institute of Technology

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Immunofluorescence Analyzer
IFA System
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.